Valuation bioMérieux

Equities

Real-time Euronext Paris Other stock markets 09:56:05 13/01/2026 GMT			5-day change	1st Jan Change
107.10 ^EUR	-2.10%		-4.55%	-2.90%

01-07	BioMérieux Slips Despite Intensifying Flu Season Across the Atlantic
12-04	Biomerieux Launches Leading Endocrinology Testing Offer Dedicated to Enhancing Equine Health	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	13,654	14,780	11,591	11,883	12,214	12,917	12,917	-
Change	-	8.25%	-21.58%	2.52%	2.78%	5.76%	0%	-
Enterprise Value (EV) ¹	13,746	14,439	11,544	12,049	12,255	12,589	12,250	11,867
Change	-	5.04%	-20.05%	4.38%	1.7%	2.73%	-2.69%	-3.13%
P/E ratio	33.8x	24.7x	25.6x	33.4x	28.4x	27.8x	22.8x	20.2x
PBR	5.62x	4.75x	-	3.19x	2.92x	2.84x	2.59x	2.35x
PEG	-	0.5x	-1x	-1.6x	1.4x	3.45x	1x	1.6x
Capitalization / Revenue	4.38x	4.38x	3.23x	3.23x	3.07x	3.13x	2.95x	2.75x
EV / Revenue	4.41x	4.28x	3.22x	3.28x	3.08x	3.05x	2.8x	2.53x
EV / EBITDA	16.7x	14x	13.4x	14.6x	13.4x	12.4x	11.2x	9.72x
EV / EBIT	23.1x	18.4x	19.7x	27.4x	19.9x	17.9x	15.7x	13.6x
EV / FCF	45x	27.7x	59.1x	105x	37.2x	22.7x	27.1x	22.6x
FCF Yield	2.22%	3.61%	1.69%	0.96%	2.69%	4.41%	3.69%	4.42%
Dividend per Share ²	0.62	0.85	0.85	0.85	0.9	0.9094	1.158	1.27
Rate of return	0.54%	0.68%	0.87%	0.84%	0.87%	0.83%	1.06%	1.16%
EPS ²	3.41	5.06	3.82	3.01	3.64	3.933	4.803	5.42
Distribution rate	18.2%	16.8%	22.3%	28.2%	24.7%	23.1%	24.1%	23.4%
Net sales ¹	3,118	3,376	3,589	3,675	3,980	4,124	4,372	4,695
EBITDA ¹	823.5	1,032	864.2	827	913.9	1,013	1,094	1,221
EBIT ¹	595.1	784.3	587.2	439	614.7	701.4	779.5	870.5
Net income ¹	404.4	601.1	452.4	358	432	466	563.6	634.6
Net Debt ¹	92.1	-341	-47	166	40.9	-327.9	-666.8	-1,050
Reference price ²	115.40	124.90	97.92	100.60	103.50	109.40	109.40	109.40
Nbr of stocks (in thousands)	118,316	118,336	118,374	118,124	118,006	118,067	118,067	-
Announcement Date	24/02/21	02/03/22	07/03/23	14/03/24	07/03/25	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOMÉRIEUX	27.81x	3.05x	12.43x	0.83%	15.08B
GUARDANT HEALTH, INC.	-34.89x	14.88x	-67.17x	-.--%	13.86B
CARIS LIFE SCIENCES, INC.	-20x	9.35x	108.54x	-	7.22B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	28.19x	9.82x	22.61x	1.98%	6.81B
DIASORIN S.P.A.	21.4x	3.7x	11.2x	1.62%	4.63B
LANTHEUS HOLDINGS, INC.	21.43x	3.09x	8.39x	-	4.47B
AUTOBIO DIAGNOSTICS CO., LTD.	18.29x	-	-	3.32%	3.06B
10X GENOMICS, INC.	-39.48x	3.22x	-43.89x	-.--%	2.51B
Average	2.84x	6.73x	7.44x	1.29%	7.21B
Weighted average by Cap.	2.35x	7.80x	3.18x	0.95%